Anti-CD19 CAR T cells for refractory myasthenia gravis

Lancet Neurol. 2023 Dec;22(12):1104-1105. doi: 10.1016/S1474-4422(23)00375-7.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Myasthenia Gravis* / therapy
  • T-Lymphocytes*